A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Link
https://link.springer.com/content/pdf/10.1007/s13691-022-00562-x.pdf
Reference24 articles.
1. Takahashi E, Nakamura S (2013) Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop 53:1–8
2. Skala SL, Lucas DR, Dewar R (2018) Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med 142:1322–1329
3. Auerbach A, Schmieg JJ, Aguilera NS (2021) Pediatric lymphoid and histiocytic lesions in the head and neck. Head Neck Pathol 15:41–58
4. Vos JA, Abbondanzo SL, Barekman CL et al (2005) Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 18:693–704
5. Kommalapati A, Tella SH, Durkin M et al (2018) Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood 131:265–268
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Remission with Novel Combined Immune-Targeted Treatment for Histiocytic Sarcoma Accompanied by Follicular Lymphoma: Case Report and Literature Review;International Journal of Molecular Sciences;2024-07-02
2. One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas;Veterinary and Comparative Oncology;2024-06-12
3. Pembrolizumab Combined With GDP Regimen Inducing Sustained Remission in Histiocytic Sarcoma: A Case Report;Journal of Investigative Medicine High Impact Case Reports;2024-01
4. Favorable outcome of a histiocytic sarcoma patient treated with immune checkpoint inhibitor: a case report;Annals of Medicine & Surgery;2023-11-01
5. Antineoplastics;Reactions Weekly;2023-01-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3